Matthew Pollman, MD, has held a number of leadership positions in the development of cardiovascular therapeutics and diagnostics.
He has most recently served as Medical Director, R&D, for Abbott Vascular.
In this role, Dr. Pollman
was the principal medical and scientific advisor for the R&D and Business Development organizations.
Prior to this role, Dr. Pollman was the Director of New Ventures, Guidant Corporation where he led a multi-disciplinary in-house start-up incubator tasked with identifying, exploring and incubating through PhaseI/PhaseII clinical trials, novel therapeutic opportunities utilizing emerging device or combination product technologies.
Dr. Pollman has also directed therapeutic/diagnostic target discovery and development efforts as Director of Cardiovascular Biology and Molecular Medicine for Millennium Pharmaceuticals.
Dr. Pollman is a cardiologist and cardiovascular molecular biologist and has authored numerous peer-reviewed journal articles.
has served on the faculties of Harvard Medical School
and Morehouse School of Medicine